# Completeness Review: erol-enzyme-aave-fork-protocol-more

**Review date:** 2026-07-18

## Assessment basis

Static inspection of project-owned source and configuration only; no dependency installation, build, database migration, external-service call, or runtime launch was performed. The scan considered 74 project files (18 source files), 1 manifest(s), 0 test-like file(s), and 0 CI workflow(s), excluding dependency/generated directories.

## Classification

**Not an app**

This repository is a quarantined historical integration reference with a
paper-only TypeScript library and bounded demo, not an independently runnable
application. It intentionally has no provider, signer, service listener,
browser surface, identity store, or login/session endpoint, and its former
live mutation commands fail closed.

## Why it is not complete

- The supported build/runtime path and a trustworthy end-to-end workflow have not been demonstrated from the checked-in state.

## Needed features

1. Establish provenance/licensing and reproduce a clean build in an isolated environment before adding product surface.
2. Integrate licensed market/bank/broker data with idempotent ingestion, reconciliation, and explicit source timestamps.
3. Add deterministic exposure, liquidity, loss, approval, and kill-switch limits outside any LLM decision path.
4. Implement ledger-grade transaction history, corporate-action/error correction, custody boundaries, and audit exports.
5. Backtest and paper-trade realistic failure, stale-data, duplicate-order, and partial-fill scenarios before live use.

## Risks or launch blockers

- Regression risk is high because no recognizable project-owned automated tests cover the main path.
- No CI evidence prevents broken or insecure changes from reaching a release.

## Evidence inspected

- `README.md`
- `src/abis/MaxConcentration.json:257`
- `src/example/main.ts`
- `package.json`

## Recommended next action

Quarantine execution, repair provenance/secret/startup/build blockers in an isolated branch, and reassess only after a clean reproducible build and smoke test.

## Implementation progress (2026-07-19)

- Quarantined the repository as a private, `UNLICENSED`, paper-only historical reference. Package publishing, account funding, Aave deposit/borrow, and Enzyme create/approve/invest/redeem paths now fail closed before using a signer, nonce, or provider; the package entry point and supported TypeScript build include only the paper/safety boundary.
- Removed the committed private key, credential-bearing Infura URL, raw signed pending transaction, compiler input, auto-executing live examples, stale generated live package output, unused live dependencies, and the conflicting Yarn lockfile. The removed credentials remain in Git history and must be considered compromised and revoked by their owners.
- Documented the exact repository baseline, ownership, dependency history, incomplete Aave provenance, mixed Enzyme GPL-3.0/OpenZeppelin MIT metadata, licensing blocker, maintenance strategy, custody boundary, and extraction requirements in `PROVENANCE.md` and `repository-policy.json`.
- Reduced 40 Enzyme deployment artifacts to address-and-ABI-only files. `src/abis/provenance-manifest.json` preserves each original SHA-256, sanitized SHA-256, compiler/target metadata, and embedded license identifiers; six ABI-only Aave files are explicitly marked as unresolved provenance.
- Added a deterministic paper engine with integer-minor-unit exposure, concentration, liquidity, loss, approval, freshness, source-license, and kill-switch checks outside any model path; idempotent timestamped market ingestion; cross-source reconciliation; duplicate-order/fill handling; partial fills; overfill rejection; append-only correction events; and a SHA-256 hash-chained JSONL audit export.
- Added CI, credential-free runtime configuration, a safe paper demo, and quarantine checks that verify package isolation, mutation guards, ABI hashes/sanitization, provenance policy, and absence of committed credentials.
- Verified a clean `npm ci`, clean TypeScript build, paper demo, 25 project-owned safety assertions, fail-closed publish behavior, quarantine checks, `npm audit --omit=dev` with 0 vulnerabilities across the three-package supported tree, and `git diff --check`. No live market-data vendor, custody integration, public-chain deployment, or production release is claimed; those remain launch blockers for a separately owned product.

## Runtime verification disposition (2026-07-20)

The correct executable validation is `npm test` and the bounded
`npm run paper:demo` command. Authentication is not applicable. No root
`start.sh` is provided intentionally because creating a long-running service
would contradict the repository's quarantine and paper-only safety boundary.

Current verification: `npm test` rebuilt the supported tree, passed 25 safety
assertions, and passed the quarantine check. `npm run paper:demo` then produced
an approved paper-only decision and hash-chained ledger event without opening
a listener or enabling a live path.
